Formulation development and evaluation of sustained release matrix tablet of lamivudine using tamarind seed polysaccharide

Der Pharmacia Lettre

Volumn 3, Issue 4, 2011, Pages 20-28

  Alka, Arkhel ^a   Laxmi, Bhumarkar ^a   Suman, Ramteke ^a  

^a Rajiv Gandhi Proudyogiki Vishwavidyalaya   (India)

Author keywords

Hydrophilic matrix; Lamivudine; Matrix tablets; Tamarind seed polysaccharide; Treatment of HIV

Indexed keywords

ETHYL CELLULOSE; EXCIPIENT; LAMIVUDINE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; POLYSACCHARIDE; TAMARIND SEED POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTENT UNIFORMITY; CONTROLLED STUDY; DISSOLUTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE KINETICS; DRUG STABILITY; EXPERIMENTAL RABBIT; FEASIBILITY STUDY; HUMIDITY; IN VIVO STUDY; KINETICS; MATRIX TABLET; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLANT SEED; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; TABLET WEIGHT VARIATION; TAMARIND; TEMPERATURE SENSITIVITY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 80052827141     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. M. Vazquez, B. Perez-Marcos, J.L. Gomez-Amoza, Martines, R. Pacheco, C. Souto, Concheiro, Drug Dev Ind Pharm, 1992, 18, 1355-75.
2. M.C. Bonferoni, S. Rossi, M. Tamayo, J.L. Pedraz, G.A. Dominguez, C. Caramella, J Control Release, 1993, 26, 119-27.
3. J.L. Ford, M.H. Ribinstein, F. McCaul, J.E. Hogan, P.J. Edgar. Int J Pharm, 1987, 40, 223-34.
4. M.M. Talukdar, J. Plaizier-Vercammen. Drug Dev Ind Pharm, 1993, 19(9), 1037-46.
5. J. Sujja-areevath, D.L. Munday, P.J. Cox, K.A. Khan, Int J Pharm,1996, 139, 53-62.
6. P. Khullar, R.K. Khar, S.P. Agarwal, Drug Dev Ind Pharm, 1998, 24(11): 1095-99.
7. P.S. Rao, T.P. Ghosh, S. Krishna, J Sci Ind Research, 1946, 4, 705.
8. M. Sano, E. Miyata, S. Tamano, A. Hagiwara, N. Ito, T. Shirai. Food and Chem Toxicol, 1996, 34, 463-467.
9. S. Burgalassi, L. Panichi, M.F. Saettone, J. Jacobsen, M.R. Rassing, Int J Pharm, 1996, 133:1-7.
10. P.S. Rao, H.C. Srivastava, Tamarind, in Whistler RL (ed), Industrial Gums. 2nd ed., Academic Press, New York, 1973, 369-411.
11. M.J. Gidley, P.J. Lillford, D.W. Rowlands, Carbohydrate Res., 1991, 214: 299-314.
12. S.F. Anthony and H.L. Clifford. Human immunodeficiency virus (HIV) disease, AIDS and related disorders. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill, 2001, 1852-1913.
13. J.D. Betty, Human immunodeficiency virus (HIV) antiretroviral therapy. In: Herfindal ET, Gourley DR, eds. Textbook of Therapeutics: Drug and Disease Management. Philadelphia, PA: Lippincott Williams & Wilkins, 2000, 1555-82.
14. G. Moyle, Clin Ther, 2000, 22(8), 911-936.
15. P.S. Rao, T.P. Ghosh and S. Krishna, J Sci Ind Research, 1946, 4, 705.
16. Government of India Ministry of Health and Family Welfare. The Pharmacopoeia of India. Delhi, India: Controller of Publication, 2007, 176-183.
17. P.R. Ravi, S. Ganga and R.N. Saha, AAPS Pharm Sci Tech. 2007, 8(4), 101.